(S)-(2- (6-Chloro-7-methyl-1H-benzo D imidazol-2-yl) -2-methylpyrrolidin-1-yl) (5-methoxy-2- (2H-1, Crystalline form of 2,3-triazol-2-yl) phenyl) methanone and its use as an orexin receptor antagonist

摘要

The present invention relates to (S)-(2- (6-chloro-7-methyl-1H-benzo [d] imidazol-2-yl) -2-methylpyrrolidin-1-yl) (5-methoxy-2- ( 2H-1,2,3-triazol-2-yl) phenyl) methanone crystal form, process for its preparation, pharmaceutical composition comprising such crystal form, pharmaceutical composition and medicament prepared from such crystal form In particular as an orexin receptor antagonist. [Selection figure] None